Sprint Bioscience AB (5JA1)

Profile

https://sprintbioscience.com/sv/

Sprint Bioscience AB is a biotechnology company specializing in the early stages of drug development. The company's primary function is to accelerate the discovery and development of novel oncology pharmaceuticals. Utilizing state-of-the-art technology platforms, Sprint Bioscience focuses on identifying and validating new cancer targets, with the aim of creating small molecule drugs. The company's efforts are concentrated within the oncology sector, but it also explores pathways that might have implications for broader therapeutic areas. By collaborating with global pharmaceutical partners, Sprint Bioscience plays a key role in expediting the translation of laboratory findings into clinical progress. Based in Sweden, the company leverages a robust scientific community and its geographic location to impact the European and international biotech arenas positively. Through its innovative approach and strategic partnerships, Sprint Bioscience significantly contributes to advancements in personalized medicine and biotechnology, aiding in the development of treatment options that target cancer at a molecular level.